FSGS treatment possible with antidiabetes drug
The antidiabetes drug, Rosiglitazone, may prove its efficacy for protecting kidney function in patient suffering from a complication called focal segmental glomerulosclerosis (FSGS).
The finding was disclosed in a study that appeared in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN).
From News-Medical.Net:
The investigators studied 11 patients with FSGS whose condition [...]